Sort
50,496 grants matching “lung cancer”
The Duke Preclinical Research Resources for Quantitative Imaging Biomarkers
$592,709Cristian T Badea · Duke University · U24 · FY2017 · CA
Evaluation of Tobacco Treatment Strategies for Inpatient Psychiatry
$592,697Judith J. Prochaska · University Of California, San Francisco · R01 · FY2010 · MH
Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy Assay
$592,674Yun Wu · State University Of New York At Buffalo · R01 · FY2022 · CA
Infrastructure Support and Pilot Tissue Collection for the CARET Biorepository
$592,642Chu Chen · Fred Hutchinson Cancer Research Center · U01 · FY2021 · CA
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)
$592,634Jenny C-N Chang · Methodist Hospital Research Institute · U01 · FY2023 · CA
Development of a WNT Inhibitor for Advanced Stage Lung Cancer
$592,630Darren Orton · Stemsynergy Therapeutics, Inc. · R44 · FY2014 · CA
Precision Lung Cancer Survivorship Care Intervention: A Randomized Controlled Trial Serving Rural Survivors and Communities
$592,610Jamie L Studts · University Of Colorado Denver · R01 · FY2022 · CA
TARGETING TUMOR-INTRINSIC IMMUNOSUPPRESSIVE MECHANISMS TO ENHANCE EFFICACY OF IMMUNE CHECKPOINT BLOCKADE IN LUNG CANCER
$592,582Weill Medical College Of Cornell University · · FY2019 · Defense Health Agency
Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation
$592,532Cheryl A London · Tufts University Boston · U01 · FY2025 · CA
Understanding the impacts of cancer therapy, high temperature and poor air quality on heart and lung health in breast cancer survivors.
$592,402Anne C Kirchhoff · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
HLA B44 motif neoepitopes in NSCLC: Evaluating their effects on the TME and adding them to established markers in a model to predict durable benefit from PD- 1 inhibition with and without chemotherapy
$592,352Edward B Garon · University Of California Los Angeles · R01 · FY2024 · CA
The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis
$592,289William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA
S100A4 Regulation of IPF Mesenchymal Progenitor Cell Fibrogenicity
$592,286Craig A Henke · University Of Minnesota · R01 · FY2021 · HL
Modeling the SCLC Phenotypic Space
$592,269Vito Quaranta · Vanderbilt University · U54 · FY2019 · CA
Vanderbilt Network Lead Academic Participating Site for the NCTN
$592,247Jordan D Berlin · Vanderbilt University Medical Center · U10 · FY2017 · CA
PHAGOCYTOSIS--PULMONARY ALVEOLAR MACROPHAGES
$592,168Brigham And Women'S Hospital · R01 · FY2002 · HL
Evaluating prostate cancer phenotype and genotype classification from circulating tumor DNA as biomarkers for predicting treatment outcomes
$592,110Gavin Ha · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Reproductive and Developmental Toxicity of Dioxin
$592,106Richard E Peterson · University Of Wisconsin-Madison · R01 · FY2010 · ES
PROMINENT - IRB
$592,041Nuria Lopez-Bigas · Fundacio Institut De Recerca Biomedica · OT2 · FY2022 · CA
World Trade Center Particulate Matter Induced Cardiorespiratory and Vascular Dysfunction: a MultiOmic Approach
$592,037Anna Nolan · New York University School Of Medicine · U01 · FY2021 · OH
The Worcester Venous Thromboembolism Study
$591,996Frederick A Spencer · Univ Of Massachusetts Med Sch Worcester · R01 · FY2009 · HL
Colorectal Tumor Risk Prediction in the PLCO Trial
$591,978Ulrike Peters · Fred Hutchinson Cancer Research Center · U01 · FY2016 · CA
Tumor and Metastasis Biology
$591,974Lee J. Helman · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Functional Determinants of Metastatic Dormancy
$591,949Julio A Aguirre-Ghiso · Albert Einstein College Of Medicine · R01 · FY2024 · CA
Computer Support for the Colon Cancer Screening in PLCO Cancer Screening Trials
$591,908William Lake · Information Management Services, Inc. · N02 · FY2010 · CA